NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

SARS-CoV-2 -RNA persists longer in faecal sample as compared to nasal and throat swab samples of COVID-19 patients'; an observational study.

Author(s): Prakash S, Shukla S, Mishra H, Prakash O, Khan DN, Pandey A, Reddy DH, Jain A

Publication: Indian J Med Microbiol, 2021, Vol. 39, Page 122-124

PubMed ID: 33610243 PubMed Review Paper? No

Purpose of Paper

This paper compared the detection of SARS-CoV-2, the virus that causes the novel 2019 coronavirus disease (COVID, COVID-19, COVID19), in matched nasal swab, oropharyngeal swab, serum, urine, and fecal specimens using real-time qRT-PCR over the course of the patient’s hospitalization.

Conclusion of Paper

SARS-CoV-2 RNA was not detected in any urine or serum specimens but was detected in nasal swab, oropharyngeal swab, or feces for a minimum of 9 days and a maximum of 24 days. Fecal specimens were positive for viral RNA for 3-5 days after nasal and oropharyngeal swab specimens were negative.

Studies

  1. Study Purpose

    This study compared the detection of SARS-CoV-2 in matched nasal swab, oropharyngeal swab, serum, urine, and fecal specimens using real-time qRT-PCR over the course of the patient’s hospitalization. Specimens were collected from nine hospitalized patients (aged=2.6-53 y) every other day for up to 4 weeks after hospital admission (specimen collection, processing, and storage details not provided). Viral RNA was extracted using the PureLink DNA/RNA Mini Kit. SARS-CoV-2-E-gene and RNase P were detected by real-time qRT-PCR and SARS-CoV-2- RdRp and ORF1b were used in a confirmatory assay. The cycle threshold cutoff for determining a positive specimen was not provided.

    Summary of Findings:

    SARS-CoV-2 RNA was not detected in any urine or serum specimens but was detected in at least one specimen type (nasal swab, oropharyngeal swab, or feces) for a minimum of 9 days and a maximum of 24 days. SARS-CoV-2 RNA was detected in oropharyngeal swabs for the shortest span of days (5-15 days) and detection was lost earlier in the timecourse compared to nasal swab and fecal specimens in eight of nine patients. SARS-CoV-2 RNA was detected in nasal swabs specimens for a range of 7-19 days. SARS-CoV-2 l RNA was detected in fecal specimens for 4-22 days and continued to be detected in specimens from all patients for 3-5 days after loss of detection in nasal and oropharyngeal swab specimens.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Pneumonia/Respiratory Infection
    Platform:
    AnalyteTechnology Platform
    RNA Real-time qRT-PCR
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Real-time qRT-PCR Specific Targeted nucleic acid SARS-CoV-2-E-gene
    SARS-CoV-2-RdRp
    RNase P
    SARS-CoV-2-ORF1b
    Biospecimen Acquisition Biospecimen location Feces
    Serum
    Urine
    Nasal cavity
    Oral cavity

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...